Newton Biocapital

Avenue De Tervueren 273

1150 Woluwe-Saint-Pierre

BE

Newton Biocapital

Foundation date

07/04/2017

Sector

#Investor

Subsector

Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases.

Our approach as lead investor is to support promising start-up projects as well as neglected or undervalued late-stage projects, in order to mitigate the risks and to create investor value. The leadership team consists of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects.

Upcoming events

Latest news

  • Scientists discover viral trapdoor blocking HIV and herpes

    1 day ago

  • UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility

    Tuesday October 8th 2024

  • Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

    Monday October 7th 2024